SCHEMBL7710995

SCHEMBL7710995

CCCC1Oc2ccc(C(C)(NC(=O)OC(C)(C)C)c3cccs3)cc2N=C1N

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.32
CTSL P07711 1/20 0.32
CTSS P25774 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7704894 0.93 CTSK (0.31) CTSKCTSLCTSS
SCHEMBL7708340 0.87 ALDH1A1 (0.32)
SCHEMBL7711367 0.82 USP2 (0.38)
SCHEMBL7711396 0.82 CTSK (0.32) CTSKCTSLCTSS
Hydrochloric Acid SCHEMBL7710760 0.80 ESR1 (0.32)
SCHEMBL7713259 0.77 USP2 (0.39)
SCHEMBL7708245 0.76 SMN1; SMN2 (0.31) CTSKCTSS
SCHEMBL7710991 0.74 CTSK (0.32) CTSKCTSLCTSS
SCHEMBL7704890 0.73 CTSK (0.32) CTSKCTSLCTSS
SCHEMBL7708334 0.73 ALDH1A1 (0.32) CTSKCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed